Inflammatory myopathy following COVID-19 mRNA vaccination in a patient with VEXAS syndrome.

Autor: Kakurai M; Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan., Honda R; Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan., Tsuchida N, Maeda A; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Uchiyama Y; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan, Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan., Matsumoto N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Ito S; Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan.
Jazyk: angličtina
Zdroj: European journal of dermatology : EJD [Eur J Dermatol] 2024 Oct 01; Vol. 34 (5), pp. 545-546.
DOI: 10.1684/ejd.2024.4760
Databáze: MEDLINE